Compare TRAK & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRAK | NAUT |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.5M | 245.0M |
| IPO Year | 1998 | N/A |
| Metric | TRAK | NAUT |
|---|---|---|
| Price | $11.25 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 104.3K | ★ 205.6K |
| Earning Date | 02-11-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 19.98 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $23,136,391.00 | N/A |
| Revenue This Year | $8.29 | N/A |
| Revenue Next Year | $24.17 | N/A |
| P/E Ratio | $31.09 | ★ N/A |
| Revenue Growth | ★ 11.05 | N/A |
| 52 Week Low | $10.69 | $0.62 |
| 52 Week High | $23.72 | $2.54 |
| Indicator | TRAK | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 34.00 | 62.73 |
| Support Level | $10.69 | $1.75 |
| Resistance Level | $12.15 | $2.29 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 28.97 | 95.41 |
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.